Eupraxia Pharmaceuticals Market Cap

Eupraxia Pharmaceuticals has a market cap or net worth of CAD 174.91 million as of November 22, 2024. Its market cap has increased by 8.00% in one year.

Market Cap

174.91M

Enterprise Value

161.25M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

4.91

Market Cap Chart

Since March 9, 2021, Eupraxia Pharmaceuticals's market cap has increased from 78.01M to 174.91M, an increase of 124.22%. That is a compound annual growth rate of 24.36%.

Market Cap History

Date	Market Cap	% Change
Nov 20, 2024	179.18M	22.39%
Dec 29, 2023	146.40M	85.76%
Dec 30, 2022	78.81M	125.87%
Dec 31, 2021	34.89M	-55.27%
Mar 9, 2021	78.01M	-

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Bausch + Lomb Corporation	9.64B
Bausch Health Companies Inc.	4.20B
Curaleaf Holdings, Inc.	2.05B
dentalcorp Holdings Ltd.	1.77B
Tilray Brands, Inc.	1.69B
Sienna Senior Living Inc.	1.39B
WELL Health Technologies Corp.	1.29B
Cronos Group Inc.	1.11B

Market Cap Rankings